BEAT-meso: Bevacizumab and Atezolizumab in Malignant Pleural Mesothelioma

Clinical trial NCT03762018 · COMPLETED

Trial details

NCT number: NCT03762018
Sponsor: ETOP IBCSG Partners Foundation
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Pleural Mesothelioma Malignant Advanced

Start date: 2019-04-30
Primary completion: 2023-09-01
Enrollment: 400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.